Simvastatin and Pancreatitis necrotising - a phase IV clinical study of FDA data

Summary:

Pancreatitis necrotising is found among people who take Simvastatin, especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years.

The phase IV clinical study analyzes which people take Simvastatin and have Pancreatitis necrotising. It is created by eHealthMe based on reports of 230,650 people who have side effects when taking Simvastatin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 20, 2023

230,650 people reported to have side effects when taking Simvastatin.
Among them, 110 people (0.05%) have Pancreatitis necrotising.

What is Simvastatin?

Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 238,086 Simvastatin users for its effectiveness, alternative drugs and more.

What is Pancreatitis necrotising?

Pancreatitis necrotising (inflammation of the pancreas cause death of tissue in pancreas) is found to be associated with 735 drugs and 348 conditions by eHealthMe.

Number of Simvastatin and Pancreatitis necrotising reports submitted per year:

Could Simvastatin cause Pancreatitis necrotising?

* Approximation only. Some reports may have incomplete information.

Do you take Simvastatin and have Pancreatitis necrotising?

Check whether Pancreatitis necrotising is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Pancreatitis necrotising and when was it recovered:

Pancreatitis necrotising in Simvastatin

Expand to all the drugs that have ingredients of simvastatin:

Pancreatitis necrotising and drugs with ingredients of simvastatin

Alternative drugs to, pros and cons of Simvastatin:

Simvastatin (238,086 reports)

Common Simvastatin side effects:

Fatigue (feeling of tiredness): 14,139 reports
Weakness: 12,078 reports
Breathing difficulty: 11,987 reports
Diarrhea: 11,131 reports
Dizziness: 11,127 reports

Browse all side effects of Simvastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pancreatitis necrotising treatments and more:

Pancreatitis necrotising (2,213 reports)

COVID vaccines that are related to Pancreatitis necrotising:

Common drugs associated with Pancreatitis necrotising:

All the drugs that are associated with Pancreatitis necrotising:

Pancreatitis necrotising (735 drugs)

Common conditions associated with Pancreatitis necrotising:

High blood pressure: 219 reports
Type 2 diabetes: 145 reports

All the conditions that are associated with Pancreatitis necrotising:

Pancreatitis necrotising (348 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on simvastatin (the active ingredients of Simvastatin) and Simvastatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.